The Business Research Company’s Antibody Drug Conjugates Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Antibody Drug Conjugates Global Market Report 2023 evaluates antibody drug conjugates market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp
The global antibody drug conjugates market grew from $5.9 billion in 2022 to $7.2 billion in 2023 at a compound annual growth rate (CAGR) of 22.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The antibody drug conjugates market is expected to grow from $16.15 billion in 2027 at a CAGR of 22.4%.
The antibody drug conjugates market segments in the report are:
1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Other Types
2) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications
3) By Product: Adcertis, Kadcyla, Other Products
4) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology
5) By End User: Hospital, Clinics, Other End Users
Get More Information On The Antibody Drug Conjugates Market Report:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Top 5 Major Key Players Are:
Bayer AG
Concortis Biotherapeutics
F. Hoffmann-La Roche Ltd
Immunomedics Inc
Oxford BioTherapeutics
Table Of Contents
1. Executive Summary
2. Antibody Drug Conjugates Market Characteristics
3. Antibody Drug Conjugates Market Trends And Strategies
4. Antibody Drug Conjugates Market – Macro Economic Scenario
5. Antibody Drug Conjugates Market Size And Growth
…….
27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles
28. Antibody Drug Conjugates Pipeline Analysis
29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market
30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis
31. Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
